| The evolutionary history of 2,658 cancers M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ... Nature 578 (7793), 122-128, 2020 | 903 | 2020 |
| Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ... Nature communications 6 (1), 6605, 2015 | 397 | 2015 |
| Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... Cell 184 (8), 2239-2254. e39, 2021 | 310 | 2021 |
| Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads J Schröder, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ... Bioinformatics 30 (8), 1064-1072, 2014 | 101 | 2014 |
| A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance N Sapre, G Macintyre, M Clarkson, H Naeem, M Cmero, A Kowalczyk, ... British journal of cancer 114 (4), 454-462, 2016 | 97 | 2016 |
| Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone KL Owen, LJ Gearing, DJ Zanker, NK Brockwell, WH Khoo, DL Roden, ... EMBO reports 21 (6), e50162, 2020 | 69 | 2020 |
| Inferring structural variant cancer cell fraction M Cmero, K Yuan, CS Ong, J Schröder, NM Corcoran, T Papenfuss, ... Nature communications 11 (1), 730, 2020 | 46* | 2020 |
| Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... BioRxiv, 312041, 2018 | 43 | 2018 |
| Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis TM Johanson, AA Keown, M Cmero, JHC Yeo, A Kumar, AM Lew, Y Zhan, ... Nature Immunology 16 (11), 1134-1141, 2015 | 36 | 2015 |
| Comparing nodal versus bony metastatic spread using tumour phylogenies S Mangiola, MKH Hong, M Cmero, N Kurganovs, A Ryan, AJ Costello, ... Scientific reports 6 (1), 33918, 2016 | 24 | 2016 |
| MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data M Cmero, B Schmidt, IJ Majewski, PG Ekert, A Oshlack, NM Davidson Genome Biology 22, 1-26, 2021 | 21 | 2021 |
| Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression R Stuchbery, G Macintyre, M Cmero, LM Harewood, JS Peters, ... Oncotarget 7 (21), 31384, 2016 | 17 | 2016 |
| Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy M Cmero, NJ Kurganovs, R Stuchbery, P McCoy, C Grima, A Ngyuen, ... JCO Precision Oncology 5, 1048-1059, 2021 | 15 | 2021 |
| Using equivalence class counts for fast and accurate testing of differential transcript usage M Cmero, NM Davidson, A Oshlack F1000Research 8, 2019 | 13 | 2019 |
| A microRNA expression atlas of mouse dendritic cell development TM Johanson, M Cmero, J Wettenhall, AM Lew, Y Zhan, MMW Chong Immunology and Cell Biology 93 (5), 480-485, 2015 | 13 | 2015 |
| MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer P McCoy, S Mangiola, G Macintyre, R Hutchinson, B Tran, B Pope, ... Prostate cancer and prostatic diseases 24 (4), 1167-1180, 2021 | 7 | 2021 |
| Pervasive intra-tumour heterogeneity and subclonal selection across cancer types S Dentro, I Leshchiner, K Haase, J Wintersinger, A Deshwar, M Tarabichi, ... Cancer Research 78 (13_Supplement), 3000-3000, 2018 | 7 | 2018 |
| Slinker: Visualising novel splicing events in RNA-Seq data AO Breon Schmidt, Marek Cmero, Paul Ekert, Nadia Davidson F1000 Research 10, 2021 | | 2021 |
| MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data M Cmero, B Schmidt, IJ Majewski, PG Ekert, A Oshlack, NM Davidson Genome Biology 22 (296), 2020 | | 2020 |
| Investigating the evolution of structural variation in cancer M Cmero University of Melbourne, 2017 | | 2017 |
